ClearHemograsper
Device Facts
| Record ID | K242857 |
|---|---|
| Device Name | ClearHemograsper |
| Applicant | Finemedix Co., Ltd. |
| Product Code | KGE · Gastroenterology, Urology |
| Decision Date | May 21, 2025 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 876.4300 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
ClearHemograsper has been designed to be used with endoscopes to cauterize and coagulate or to perform hemostasis using high-frequency current within the digestive tract.
Device Story
Monopolar endoscopic instrument; used for coagulation and hemostasis during procedures like Endoscopic Submucosal Dissection (ESD). Device components: slider, catheter tube, jaw pair, plug, irrigation port. Operator: physician; location: digestive tract via endoscope working channel. Input: high-frequency current from external electrosurgical unit. Operation: physician manipulates slider to open/close jaws to grasp bleeding site; delivers high-frequency current to cauterize/coagulate tissue. Irrigation port allows injection of saline/distilled water to clear foreign substances. Output: thermal coagulation of tissue. Benefit: effective hemostasis during endoscopic surgery.
Clinical Evidence
No clinical data. Bench testing only. Performance validated via dimension, rotatability, pushability, actuation, tensile strength, output value, hemostatic performance, short circuit, and catheter tube temperature tests. Biocompatibility confirmed per ISO 10993-1, -5, -10, -11, -23. Electrical safety/EMC confirmed per IEC 60601-1, -1-2, -2-2, -2-18.
Technological Characteristics
Monopolar electrosurgical accessory. Materials: stainless steel, polytetrafluoroethylene. Energy: high-frequency current (2500 Vp). Dimensions: 1650mm-2300mm length; 2.8mm/3.2mm diameter. Connectivity: plug for electrosurgical unit. Sterilization: EO (SAL 10^-6). Standards: ISO 10993, IEC 60601-1, IEC 60601-1-2, IEC 60601-2-2, IEC 60601-2-18, ISO 11135.
Indications for Use
Indicated for use with endoscopes to cauterize, coagulate, or perform hemostasis via high-frequency current within the digestive tract.
Regulatory Classification
Identification
An endoscopic electrosurgical unit and accessories is a device used to perform electrosurgical procedures through an endoscope. This generic type of device includes the electrosurgical generator, patient plate, electric biopsy forceps, electrode, flexible snare, electrosurgical alarm system, electrosurgical power supply unit, electrical clamp, self-opening rigid snare, flexible suction coagulator electrode, patient return wristlet, contact jelly, adaptor to the cord for transurethral surgical instruments, the electric cord for transurethral surgical instruments, and the transurethral desiccator.
Predicate Devices
- Electrosurgical Hemostatic Forceps Series (K062517)
Submission Summary (Full Text)
{0}
FDA U.S. FOOD & DRUG ADMINISTRATION
May 21, 2025
Finemedix Co., Ltd.
% Woo Seok Jeong
Manager
KMC, Inc.
Room no. 1709, 123, Digital-ro 26-gil, Guro-gu
Seoul, 08390
Korea, South
Re: K242857
Trade/Device Name: ClearHemograsper
Regulation Number: 21 CFR 876.4300
Regulation Name: Endoscopic Electrosurgical Unit And Accessories
Regulatory Class: Class II
Product Code: KGE
Dated: April 24, 2025
Received: April 24, 2025
Dear Woo Seok Jeong:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov
{1}
K242857 - Woo Seok Jeong
Page 2
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-
{2}
K242857 - Woo Seok Jeong
Page 3
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
SIVAKAMI VENKATACHALAM -S
for
Shanil Haugen
Assistant Director
DHT3A: Division of Renal, Gastrointestinal,
Obesity, and Transplant Devices
OHT3: Office of Gastrorenal, ObGyn,
General Hospital, and Urology Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
{3}
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120
Expiration Date: 07/31/2026
See PRA Statement below.
Submission Number (if known)
K242857
Device Name
ClearHemograsper
Indications for Use (Describe)
ClearHemograsper has been designed to be used with endoscopes to cauterize and coagulate or to perform hemostasis using high-frequency current within the digestive tract.
Type of Use (Select one or both, as applicable)
☑ Prescription Use (Part 21 CFR 801 Subpart D)
☐ Over-The-Counter Use (21 CFR 801 Subpart C)
# CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{4}
FINEMEDIX
K242857
Page 1 of 6
# 510(k) Summary
This summary of 510(K) – safety and effectiveness information is being submitted in accordance with requirements of 21 CFR Part 807.92.
Date: July 19, 2024
# 1. Applicant / Submission Sponsor
FINEMEDIX CO., LTD.
Address: Headquarters: 140-9, Yuram-ro, Dong-gu, Daegu, 41059, REPUBLIC OF KOREA
Tel: +82-53-741-8388
# 2. Submission Correspondent
WooSeok Jeong (Consultant, KMC, Inc.)
Address: Room no. 1709, 123, Digital-ro 26-gil, Guro-gu, Seoul, 08390, REPUBLIC OF KOREA
Tel: +82-10-7194-5723
Email: ws.jeong@kmcerti.com
# 3. Device Identification
Trade/Proprietary Name: ClearHemograsper
Common Name: Endoscopic Hemostasis Forceps
Classification Regulation: 21CFR 876.4300
Product Code: KGE
Device Class: 2
# 4. Predicate Devices
| | Predicate Device #1 |
| --- | --- |
| Manufacturer | OLYMPUS MEDICAL SYSTEMS CORP. |
| Trade Name | Electrosurgical Hemostatic Forceps Series |
| 510(k) number | K062517 |
# 5. Description
ClearHemograsper is a monopolar endoscopic instrument intended to coagulate or to perform hemostasis using high-frequency current within the digestive tract.
It can assist in endoscopic surgical procedures such as ESD (Endoscopic Submucosal
1 / 6
{5}
K242857
Page 2 of 6
Dissection). ClearHemograsper consists a Slider for opening or closing the Jaw, a Catheter Tube which is a part passing through the working channel of endoscope, a pair of Jaw for catching the bleeding site and for delivering high-frequency current, a plug for connecting with high frequency transmission equipment, and an irrigation port for removing foreign substances by injecting distilled water or saline solution. It is available in various working lengths.
## 6. Indications for use
ClearHemograsper has been designed to be used with endoscopes to cauterize and coagulate or to perform hemostasis using high-frequency current within the digestive tract.
## 7. Substantial Equivalence
The ClearHemograsper is substantially equivalent to the predicate device, Electrosurgical Hemostatic Forceps Series. (K062517, OLYMPUS MEDICAL SYSTEMS CORP.). The following comparison table is presented to demonstrate substantial equivalence.
| | Subject Device
FINEMEDIX Co., Ltd.
ClearHemograsper | Predicate Device
OLYMPUS MEDICAL
SYSTEMS CORP.
Electrosurgical
Hemostatic Forceps
Series
(K062517) | Similarities And
Differences |
| --- | --- | --- | --- |
| Product Code | KGE | KGE | Same |
| Regulation No. | 876.4300 | 876.4300 | Same |
| Class | 2 | 2 | Same |
| Indications for
use | ClearHemograsper has been
designed to be used with
endoscopes to cauterize and
coagulate or to perform
hemostasis using high-
frequency current within the
digestive tract. | This instrument has been
designed to be used with
Olympus endoscopes to
cauterize, coagulate and
perform hemostasis using
high-frequency current
within the digestive tract. | Same |
| Supplied in
Sterile | Yes | Yes | Same |
| Sterilization | EO Sterilized, SAL:10^{-6} | EO Sterilized, SAL:10^{-6} | Same |
| Shelf Life | Three years | Three years | Same |
| Main Material | Stainless steel,
Polytetrafluoroethylene | Stainless steel,
Polyethylene | Similar.
The minor gap does
not affect the
performance of the
product, and the
safety has been
proven
by ISO 10993-1 test
reports. |
| Configuration | Jaws, Tube, Plug, Slider | Jaws, Tube, Plug, Slider | Same |
| Working length | 1650mm ~ 2300mm | 1650mm ~ 2300mm | Same |
2 / 6
{6}
K242857
Page 3 of 6
FINEMEDIX
| Jaws Type | Type 1
Type 2 | Type A
Type B
Type C | Same |
| --- | --- | --- | --- |
| Maximum Diameter | ≤2.8 mm / ≤3.2 mm | ≤2.75 mm / ≤3.1 mm | Similar.
The minor gap does not affect the performance and safety of the product. |
| Energy Used/Delivered | Monopolar Radio Frequency Current. | Monopolar Radio Frequency Current. | Same |
| Rated High-Frequency Voltage | COAG: 2500 Vp (5000 Vp-p) | COAG: 2900 Vp (5800 Vp-p) | Different |
| Biological Performance | Conform to ISO 10993-1 | Conform to ISO 10993-1 | Same |
| Electrical Safety and Electromagnetic Compatibility | Conform to:
IEC60601-1
IEC 60601-1-2
IEC 60601-2-2
IEC 60601-2-18 | Conform to:
IEC60601-1
IEC 60601-1-2
IEC 60601-2-2
IEC 60601-2-18 | Same |
| Single Use | Yes | Yes | Same |
## Technical Characteristics
1) Same Points between subject device and predicate device
| Item | Description |
| --- | --- |
| Product Code | The product code is same between subject device and predicate device. |
| Regulation No. | The regulation number is same between subject device and predicate device. |
| Class | The class is same between subject device and predicate device. |
| Indications for use | The indications for use is same between subject device and predicate device. |
| Supplied in Sterile | The supplied in sterile is same between subject device and predicate device. |
| Sterilization | The sterilization is same between subject device and predicate device. |
| Shelf Life | The shelf life is same between subject device and predicate device. |
| Configuration | The configuration is same between subject device and predicate device. |
| Working Length | The working length is same between subject device and predicate device. |
| Jaws Type | The jaws type are same between subject device and predicate device. |
| Energy Used/Delivered | The energy used/delivered type is same between subject device and predicate device. |
| Biological Performance | The biological performance is same between subject device and predicate device. |
| Electrical Safety and Electromagnetic Compatibility | The electrical safety and electromagnetic compatibility is same between subject device and predicate device. |
| Single Use | The subject device and predicate device are single used device. It is same. |
3 / 6
{7}
FINEMEDIX
K242857
Page 4 of 6
2) Different Points between subject device and predicate device
| Item | Description |
| --- | --- |
| Main Material | The main materials of subject device are “Stainless steel, Polytetrafluoroethylene” and predicate device is “Stainless steel, Polyethylene”.
We conducted biocompatibility test for subject device, the results show that these differences do not raise different questions of safety and effectiveness. (The biocompatibility test report is attached in this submission). |
| Maximum Diameter | The maximum diameter of subject device is “2.8 mm and 3.2 mm” and predicate device is “2.75 mm and 3.1 mm”.
The difference in maximum diameter is within 5%, these differences do not raise different questions of safety and effectiveness. |
| Rated High-Frequency Voltage | The rated high-frequency voltage of subject device is “2,500 Vp” and predicate device is “2,900 Vp”.
We conducted IEC 60601-2-2 test and Hemostatic Performance test for subject device, the results show that these differences do not raise different questions of safety and effectiveness. (The biocompatibility test report is attached in this submission). |
# 8. Biocompatibility
The biocompatibility tests of patient indirect contact part (Jaw and Catheter Tube) were performed in accordance with the following FDA recognized standards.
- ISO 10993-1: 2018, Biological evaluation of medical devices -Part 1: Evaluation and testing within a risk management process
- ISO 10993-5:2009, Biological evaluation of medical devices -Part 5: Tests for in vitro cytotoxicity
- ISO 10993-10:2023, Biological evaluation of medical devices -Part 10: Tests for irritation and skin sensitization.
- ISO 10993-11:2017, Biological evaluation of medical devices -Part 11: Tests for systemic toxicity
- ISO 10993-23:2021, Biological evaluation of medical devices - Part 23: Tests for irritation
- FDA Guidance - Use of International Standard ISO 10993-1, "Biological evaluation of medical devices -Part 1: Evaluation and testing within a risk management process"
# 9. Sterility
The Duoblade is provided sterile, intended to be single-use. This product is EO-Sterilization in accordance with ISO 11135.
The sterilization test was performed in accordance with the following FDA recognized standards.
- ISO 11135:2014: Sterilization of health-care products -Ethylene oxide -Requirements for the development, validation and routine control of a sterilization process for medical device
- ISO 10993-7:2008: Biological evaluation of medical device-Part7 Ethylene oxide sterilization residuals
# 10. Shelf Life
The shelf life of the subject device is 3 years.
4 / 6
{8}
FINEMEDIX
K242857
Page 5 of 6
The validation report of the subject device shows that the difference in the shelf life does not influence the quality performance of the packaging based on the result of confirmation of physical and chemical stability and effectiveness through accelerated aging test of the samples. The validation report is provided in this submission file.
The shelf life method has been validated in accordance with the following standards.
- ASTM F1980-16: Standard Guide for Accelerated Aging of Sterile Barrier Systems for Medical Devices
- ASTM F88/F88M-15, Standard Test Method for Seal Strength of Flexible BarrierMaterials
- ISO 11607-1:2019, Packaging for terminally sterilized medical devices –Part 1: Requirements for materials, sterile barrier systems and packaging systems
- ISO 11607-2:2019, Packaging for terminally sterilized medical devices –Part 2: Validation requirements for forming, sealing and assembly processes
## 11. Electromagnetic Compatibility (EMC) and Electrical Safety
The Electromagnetic Compatibility (EMC) and Electrical Safety tests were performed in accordance with the following FDA recognized standards.
- IEC 60601-1:2005/A1:2012/A2:2020, Medical electrical equipment -Part 1: General requirements for basic safety and essential performance
- IEC 60601-1-6:2010 /A1:2013/A2:2020, Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability
- IEC 60601-2-2:2017/A1:2023, Medical electrical equipment -Part 2-2: Particular requirements for the basic safety and essential performance of high frequency surgical equipment and high frequency surgical accessories
- IEC 60601-2-18:2009, Medical electrical equipment - Part 2-18: Particular requirements for the basic safety and essential performance of endoscopic equipment
- IEC 60601-1-2:2014+A1:2020, Medical electrical equipment -Part 1-2: General requirements for basic safety and essential performance -Collateral Standard: Electromagnetic disturbances -Requirements and tests
## 12. Performance Test
The following performance tests were performed.
1) Dimension Test
2) Rotatable Performance Test
3) Pushability Test
4) Actuation Test
5) Tensile Strength Test
6) Output Value Test
7) Hemostatic Performance Test
8) Removal of the High-Frequency Plug Test
9) Short Circuit Test
10) Catheter Tube Temperature Test
5 / 6
{9}
FINEMEDIX
K242857
Page 6 of 6
## 13. Clinical Test
No clinical studies were considered for this submission.
## 14. Conclusion
In comparing between the subject device and the predicate device, there are the same Product Code, Regulation Number, Class, Indications for use, Supplied in Sterile, Sterilization, Shelf Life, Configuration, Working Length, Jaws Type, Energy Used/Delivered, Biological Performance, Electrical Safety and Electromagnetic Compatibility and Single Use.
Although the Main Material, Maximum Diameter and Rated High-Frequency Voltage are difference, these differences do not raise different questions of safety and effectiveness.
Therefore, the subject device is substantially equivalent to the predicate device.
6 / 6
